2nd Kinase Inhibitors Design and Screening Conference

GTCbio and the Advisory Board would like to invite you the 2nd Kinase Inhibitors Design and Screening Conference. This event takes place May 12-13, 2016 in Berlin, Germany. The conference brings together industry leaders from major pharmaceuticals, biotech companies, and top researchers from academia to provide a timely and critical update on significant kinase inhibitors and to better understand current trends for drug design and screening processes. This meeting's discussion and presentations will circle around recent developments in allosteric kinase inhibitors, covalent inhibitor strategies, irreversible and RAF inhibitors, mechanisms of kinase inhibitor resistance, and mutation-focused approaches towards kinase inhibition.

Session topics include:
I. Novel Tools and Technological Advances in Kinase Inhibitor Development
II. Target Identification and Validation
III. Biomarkers in Kinase Drug Discovery
IV. Kinase Inhibitors for CNS Indications
V. Kinase Inhibitor Design and Overcoming Resistance and Selectivity- Joint session with 10th Drug Design and Medicinal Chemistry